Molecular Imaging Agent Coupled With ‘Motion Frozen’ Processing Improves Heart Imaging, Siemens Healthcare And Cedars-Sinai Medical Center Study

EurekAlert! -- SALT LAKE CITY—Molecular imaging of the heart just got better, according to a study revealed at SNM’s 57th Annual Meeting. Combining a potential new imaging agent with a molecular imaging technique that reduces blur caused by the motion of the heart and lungs could lead to unprecedented image quality when conducting myocardial perfusion imaging, a procedure used to evaluate blood flow to the heart.